Mark Lubkeman is based in London, and is the current leader of Boston Consulting Group’s Biopharma Transformation business. Until recently, he was the global leader of BCG’s Biopharma business. He is a core member of the Health Care and Marketing, Sales & Pricing practices at BCG.

Since joining the firm in 2001, Mark has focused his client work on the biotech, pharma, and medical device industries, as well as the overall health care sector. He has also worked in BCG's Los Angeles and Zurich offices.

Mark has gained extensive global experience helping clients achieve competitive advantage by developing and implementing winning corporate and commercial strategies, capabilities, and organizations.

Before joining BCG, Mark headed the Los Angeles office of the Monitor Group. He was also a captain in US Army Military Intelligence.


  • Mergers and acquisitions
  • Product launch
  • Companywide transformation
  • Cost and productivity improvement
  • Postmerger integration
  • Growth strategy
  • Sales and marketing effectiveness
  • Health care, including: biotech, pharma, medical devices


  • MBA, Harvard Business School
  • BA, economics, Harvard University
Deep Expertise, Broad Experience